← All companies ← STC Manual STEL → ← STAA Medical Devices & Equipment STVN →
STE, Steris
STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention.
We offer our Customers a unique mix of innovative products and services.
The business
What it sells, where the money comes from, the kind of company it is.
The business in brief
read the 10-K →What this business is and what moves its needle, from its own SEC filings.
- What it is
- Revenue is Healthcare (71%), AST (19%) and Life Sciences (10%).
- Situation
- Serial acquirer. Goodwill and acquired intangibles are 54% of assets, with meaningful acquisition spending in 5 of the record's 10 years; much of what this business is was bought, at prices the record carries.
- What moves the needle
- Gross margin has run about 43% and operating margin about 16% through the cycle, a solid spread between what it charges and what the product costs to make. Read this kind of business on the installed base and what follows it. On its own account, the filing leans hardest on pricing power & competition, set against the numbers in what the filing emphasizes, below.
- Is it a good business?
- Return on capital has sat near the cost of capital (median 8%). By owner earnings: roughly 12% of revenue reaches owners as cash, consistently. This is price-taker territory, where the balance sheet and the cycle matter more than any multiple; the rest is in the 10-K.
Every line is arithmetic on the company's filings, shown in full in the sections below.
Where the money comes from
read the 10-K →Healthcare is 71% of revenue, with AST the other meaningful segment at 19%.
- Healthcare71%$4.2B
- AST19%$1.1B
- Life Sciences10%$589M
From the segment footnote of the company's own 10-K. Shares are of total revenue; the profit bar shows each segment's share of segment operating profit, before unallocated corporate costs.
The record
Ten years of arithmetic, read across the cycle.
The record, 2017–2026
realized figures from each filing · older years to the left| 2017’17 | 2018’18 | 2019’19 | 2020’20 | 2021’21 | 2022’22 | 2023’23 | 2024’24 | 2025’25 | 2026’26 | TTMTTMMar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||
| $2.6B | $2.6B | $2.8B | $3.0B | $3.1B | $4.2B | $4.5B | $5.1B | $5.5B | $5.9B | $5.9B | RevenueRevenue |
| 39% | 42% | 42% | 44% | 43% | 45% | 44% | 43% | 44% | 44% | 44% | Gross marginGross mgn |
| 26% | 24% | 24% | 24% | 24% | 31% | 24% | 24% | 24% | 24% | 24% | SG&A / revenueSG&A/rev |
| 2% | 2% | 2% | 2% | 2% | 2% | 2% | 2% | 2% | 2% | 2% | R&D / revenueR&D/rev |
| $226M | $400M | $411M | $537M | $548M | $478M | $791M | $836M | $867M | $1.1B | $1.1B | Operating incomeOp. inc. |
| 8.7% | 15.3% | 14.8% | 17.7% | 17.6% | 11.3% | 17.4% | 16.3% | 15.9% | 18.6% | 18.6% | Operating marginOp. mgn |
| $110M | $291M | $304M | $408M | $397M | $244M | $107M | $378M | $615M | $782M | $782M | Net incomeNet inc. |
| 40% | 18% | 17% | 18% | 23% | 25% | 54% | 28% | 23% | 25% | 25% | Effective tax rateTax rate |
| Cash flow & returns | |||||||||||
| $424M | $458M | $540M | $591M | $690M | $685M | $757M | $973M | $1.1B | $1.3B | $1.3B | Operating cash flowOp. cash |
| $188M | $178M | $226M | $197M | $219M | $553M | $553M | $565M | $476M | $487M | $487M | DepreciationDeprec. |
| $107M | ($34M) | ($14M) | ($38M) | $47M | ($170M) | $58M | ($27M) | ($100K) | $11M | $11M | Working capital & otherWC & other |
| $173M | $165M | $190M | $215M | $239M | $288M | $362M | $360M | $370M | $369M | $369M | CapexCapex |
| 6.6% | 6.3% | 6.8% | 7.1% | 7.7% | 6.8% | 8.0% | 7.0% | 6.8% | 6.2% | 6.2% | Capex / revenueCapex/rev |
| $251M | $292M | $350M | $376M | $450M | $397M | $395M | $613M | $778M | $972M | $972M | Owner earningsOwner earn. |
| 9.6% | 11.2% | 12.6% | 12.4% | 14.5% | 9.4% | 8.7% | 11.9% | 14.3% | 16.4% | 16.4% | Owner earnings marginOE mgn |
| $251M | $292M | $350M | $376M | $450M | $397M | $395M | $613M | $778M | $972M | $972M | Free cash flowFCF |
| 9.6% | 11.2% | 12.6% | 12.4% | 14.5% | 9.4% | 8.7% | 11.9% | 14.3% | 16.4% | 16.4% | Free cash flow marginFCF mgn |
| $66M | $46M | $13M | $110M | $909M | $550M | $43M | $546M | $54M | $20M | $20M | AcquisitionsAcquis. |
| $93M | $103M | $113M | $123M | $134M | $163M | $183M | $201M | $220M | $242M | $242M | Dividends paidDiv. paid |
| $98M | $65M | $81M | $51M | $15M | $56M | $309M | $12M | $211M | $236M | — | BuybacksBuybacks |
| 5% | 8% | 8% | 10% | 8% | 4% | — | 6% | 8% | 10% | 10% | ROICROIC |
| 4% | 9% | 10% | 12% | 10% | 4% | 2% | 6% | 9% | 11% | 11% | Return on equityROE |
| 1% | 6% | 6% | 8% | 7% | 1% | −1% | 3% | 6% | 8% | 8% | Retained to equityRetained/eq |
| Balance sheet | |||||||||||
| $283M | $202M | $221M | $320M | $221M | $348M | $208M | $207M | $172M | $440M | $440M | Cash & investmentsCash+inv |
| — | $528M | $565M | $586M | $609M | $799M | $865M | $1.0B | $1.0B | $1.1B | $1.1B | ReceivablesReceiv. |
| — | $206M | $208M | $264M | $315M | $575M | $604M | $675M | $581M | $632M | $632M | InventoryInvent. |
| — | $136M | $153M | $149M | $157M | $226M | $264M | $252M | $281M | $339M | $339M | Accounts payablePayables |
| — | $598M | $620M | $701M | $768M | $1.1B | $1.2B | $1.4B | $1.3B | $1.4B | $1.4B | Operating working capitalOper. WC |
| — | $990M | $1.1B | $1.2B | $1.2B | $1.9B | $2.0B | $2.9B | $2.0B | $2.4B | $2.4B | Current assetsCur. assets |
| — | $398M | $465M | $504M | $578M | $922M | $862M | $931M | $1.0B | $1.1B | $1.1B | Current liabilitiesCur. liab. |
| — | 2.5× | 2.3× | 2.4× | 2.1× | 2.0× | 2.3× | 3.1× | 2.0× | 2.1× | 2.1× | Current ratioCurr. ratio |
| $2.2B | $2.4B | $2.3B | $2.4B | $3.0B | $3.9B | $3.9B | $4.1B | $4.1B | $4.2B | $4.2B | GoodwillGoodwill |
| — | $5.2B | $5.1B | $5.4B | $6.6B | $11.4B | $10.8B | $11.1B | $10.1B | $10.7B | $10.7B | Total assetsAssets |
| — | $1.3B | $1.2B | $1.2B | $1.7B | $3.1B | $3.1B | $3.2B | $2.0B | $1.9B | $1.9B | Total debtDebt |
| — | $1.1B | $963M | $831M | $1.4B | $2.7B | $2.9B | $3.0B | $1.9B | $1.5B | $1.5B | Net debt / (cash)Net debt |
| 5.1× | 7.9× | 9.1× | 13.3× | 14.7× | 5.3× | 7.3× | 5.8× | 10.0× | 18.2× | 18.2× | Interest coverageInt. cov. |
| $2.8B | $3.2B | $3.2B | $3.4B | $3.9B | $6.5B | $6.1B | $6.3B | $6.6B | $7.2B | $7.2B | Shareholders’ equityEquity |
| 0.7% | 0.8% | 0.9% | 0.8% | 0.8% | 1.4% | 0.9% | 1.1% | 1.1% | 1.0% | 1.0% | Stock comp / revenueSBC/rev |
| Per share | |||||||||||
| 86.1M | 85.7M | 85.5M | 85.6M | 85.9M | 98.3M | 100M | 99.4M | 99.1M | 98.7M | 98.7M | Shares out (diluted)Shares |
| $30.35 | $30.57 | $32.55 | $35.39 | $36.18 | $42.95 | $45.25 | $51.70 | $55.09 | $60.14 | $60.14 | Revenue / shareRev/sh |
| $1.28 | $3.39 | $3.55 | $4.76 | $4.63 | $2.48 | $1.07 | $3.80 | $6.20 | $7.93 | $7.93 | EPS (diluted)EPS |
| $2.92 | $3.41 | $4.09 | $4.39 | $5.24 | $4.04 | $3.94 | $6.17 | $7.85 | $9.85 | $9.85 | Owner earnings / shareOE/sh |
| $2.92 | $3.41 | $4.09 | $4.39 | $5.24 | $4.04 | $3.94 | $6.17 | $7.85 | $9.85 | $9.85 | Free cash flow / shareFCF/sh |
| $1.08 | $1.20 | $1.32 | $1.44 | $1.56 | $1.66 | $1.83 | $2.02 | $2.22 | $2.45 | $2.45 | Dividends / shareDiv/sh |
| $2.01 | $1.93 | $2.22 | $2.50 | $2.79 | $2.92 | $3.61 | $3.62 | $3.73 | $3.74 | $3.74 | Cap. spending / shareCapex/sh |
| $32.64 | $37.40 | $37.18 | $39.76 | $45.18 | $66.44 | $60.62 | $63.40 | $66.63 | $72.78 | $72.78 | Book value / shareBVPS |
| 9-yr | 5-yr | |
|---|---|---|
| Revenue / share | +7.9%/yr | +10.7%/yr |
| Owner earnings / share | +14.5%/yr | +13.4%/yr |
| EPS | +22.5%/yr | +11.4%/yr |
| Dividends / share | +9.5%/yr | +9.5%/yr |
| Capital spending / share | +7.1%/yr | +6.1%/yr |
| Book value / share | +9.3%/yr | +10.0%/yr |
The year, in the company's words
the filing →Verbatim from the 10-K's management discussion. Each sentence is shown only because its subject, direction, and stated figures check out against the filed numbers on this page. The words are the company's; the arithmetic is the record's.
- Life Sciences+8.6%
“Life Sciences revenues increased 8.6% in fiscal 2026, as compared to fiscal 2025 reflecting growth across capital, consumable, and service revenues of 15.5%, 7.6%, and 4.9% , respectively.”
✓ figure matches the filed record - United States+8.1%
“United States revenues for fiscal 2026 were $4,333.8 million, representing an increase of $326.2 million, or 8.1%, over fiscal 2025 revenues of $4,007.6 million, reflecting growth in service, consumable, and capital equipment revenues.”
✓ figure matches the filed record - Ireland+1.1%
“Ireland revenues for fiscal 2026 were $108.5 million, representing an increase of $1.1 million, or 1.0%, over fiscal 2025 revenues of $107.3 million, reflecting growth in service revenues, partially offset by a decline in capital equipment revenues.”
✓ figure matches the filed record
The record, charted
FY2017–2026Each measure over its full record; the current point and the worst year marked.
Owner earnings vs. net income
Owner earningsNet incomeThe accountant's number, and the cash an owner can take; the gap is the tell.
Where the cash went
ReinvestBuybacksDividendsAcquisitionsRetainedBeyond op. cashEach year's outlays against its operating cash: the mix, and how it drifts. The hatched cap is spending beyond that year's operating cash — financed from the balance sheet or borrowing, not operations.
Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.
In fiscal 2026 the business turned $782M of profit into $972M of owner earnings: more cash than the profit line showed, after the non-cash charges and the capital it put back in.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Reported net income | $782M | $615M | $378M | $107M | $244M |
| Depreciation & amortizationnon-cash charge added back | +$487M | +$476M | +$565M | +$553M | +$553M |
| Stock-based compensationreal costnon-cash, but a real cost | +$62M | +$57M | +$57M | +$39M | +$58M |
| Working capital & othertiming of cash in and out, other non-cash items | +$11M | −$100K | −$27M | +$58M | −$170M |
| Cash from operations | $1.3B | $1.1B | $973M | $757M | $685M |
| Capital expenditurecash put back in to keep running and to grow | −$369M | −$370M | −$360M | −$362M | −$288M |
| Owner earnings | $972M | $778M | $613M | $395M | $397M |
| Owner-earnings marginowner earnings ÷ revenue | 16% | 14% | 12% | 9% | 9% |
Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $62M), owner earnings is nearer $911M.
Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.
Quality & stewardship
Returns, the balance sheet, capital allocation, and pay.
Owner’s Scorecard
Will it survive?
- Can it pay its interest? 18.2×ComfortableOperating income $1.1B ÷ interest expense $61M
What this means
Operating profit covers interest with the kind of margin Graham wanted for a defensive holding. Necessary, not sufficient, it says solvent, not cheap.
- How heavy is the debt, net of cash? $1.5B · 1.4× operating profitModest net debtCash $440M − debt $1.9B
What this means
Netting $440M of cash and short-term investments against $1.9B of debt leaves $1.5B owed, about 1.4× a year's operating profit (1.8× on the gross debt, before the cash). Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.
- Long (60+ days)DSO 67 + DIO 70 − DPO 37 days
What this means
Days cash is tied up between paying suppliers and collecting from customers. Lower is better; a long cycle means growth itself eats cash.
Is it a good business?
- Below average through the cycle9-yr median, range 4%–10%; 10% latest = NOPAT $825M ÷ invested capital $8.7BIndustry peers: median 10%
What this means
The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. The headline is the median of the last 9 years (it ran 10% most recently), so one peak or trough year doesn't set the verdict. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.
- Solid through the cycle10-yr median margin, range 9%–16%; latest $972M = operating cash $1.3B − maintenance capex $369MIndustry peers: median 11%
What this means
What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's 16% of revenue this year, a 12% median across 10 years. Treating stock comp as the real expense it is (less $62M of SBC) leaves $911M.
- Cash-backedCash from ops $1.3B ÷ net income $782M
What this means
How much of reported profit showed up as operating cash. Above 1× is reassuring; well below suggests earnings lean on accruals. One year is noisy, growth and working-capital swings distort it, and this is operating cash, not free cash. Watch the multi-year trend.
How is the cash used?
- Returns about halfDividends + buybacks $477M ÷ Owner Earnings $972M
What this means
Of $972M Owner Earnings, $477M (49%) went back to shareholders, $242M dividends, $236M buybacks. Net of $62M stock comp, the real buyback was about $174M. Returning most of it is the mark of a mature business with little left to reinvest at a high return; reinvesting most could mean a long runway, or empire-building. The split doesn't say which; the return earned on it (see ROIC) does.
- Investing or harvesting? 0.76×HarvestingCapex $369M ÷ depreciation $487M
What this means
Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.
Graham’s defensive tests · 5 of 6 met
Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.
- Adequate size PassRevenue ≥ $2B · $5.9B
What this means
Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.
- Strong liquidity PassCurrent ratio ≥ 2× · 2.09×
What this means
Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.
- Conservative debt MissDebt ≤ working capital · $1.9B vs $1.2B WC
What this means
Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.
- Earnings stability PassA profit every year (10-yr record) · no losses
What this means
Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.
- Dividend record PassUninterrupted dividends · paid every year (10)
What this means
An unbroken dividend was Graham's mark of durability. He wanted twenty years; the filings show about ten, and a single suspension breaks the streak. Non-payers, many fine modern compounders, fall outside his defensive net by design.
- Earnings growth PassEarnings +33% over the record · +152%
What this means
At least a third more earnings than a decade ago, averaging three years at each end. Net income (not per-share), so stock splits don't distort it, buybacks and dilution show up in the share-count line instead.
- Moderate price —P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
What this means
Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $6.06/share (latest year $8.02), the averaged base the calculator's gate runs on, and book value is $73.60/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.
Durability & moat, 2017–2026
Whether the record’s returns held, and what the capital reinvested earned.
- Profitable years 10 of 10
What this means
Never lost money over the record, the earnings stability Graham insisted on.
- Return on capital ≥ 15% 0 of 9 yrs
What this means
A moat shows up as a high return on invested capital that holds year after year, not one good vintage.
- Operating margin 13% → 17% (3-yr avg ends)
What this means
Through the cycle the operating margin widened — about 13% early to 17% lately, median 16% — pricing power intact or improving.
- Reinvestment, incremental ROIC 9%
What this means
Reinvested capital came back at only a modest incremental return — near the cost of capital, where extra growth adds little per dollar. The record shows whether it is a soft stretch or a thinning moat.
- Owner earnings growth +14%/yr
What this means
Owner earnings grew about 14% a year over the record.
- Worst year 2017 · 8.7% op. margin
What this means
Stayed profitable even in its hardest year, the resilience that survives recessions.
- Share count +1.5%/yr
What this means
The share count is rising, dilution works against you on a per-share basis.
- Dividend record rising
What this means
Paid and raised the dividend across the record, the continuity Graham prized.
Does AI threaten the moat?
Low contestabilityThe moat is physical, regulated or balance-sheet-funded, the kind AI cuts costs within but does not contest.
Its FY2026 10-K names artificial intelligence as a competitive threat, in language that was not in the prior year's filing.
“If our competitors deploy AI technologies more effectively than we do, we may lose market share or be unable to maintain our competitive position.”
AI is unlikely to contest a moat that is physical, regulated or balance-sheet-funded; here it reads more as a cost tool than a threat.
Read from the filing's own risk factors, paired with the industry's structure under its SIC code; the durability is read above, the price below.
All figures as filed; the source filing is linked above.
Current Position
as of fiscal year-end, Mar 31, 2026Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.
- Cash & short-term investments$440M
- Receivables$1.1B
- Inventory$632M
- Other current assets$230M
- Accounts payable$339M
- Other current liabilities$806M
From the company's latest filing.
How the cash was used, 2017–2026
Over the record, the business generated $7.6B of operating cash; how management split it reads as a balanced allocator, splitting cash between the business, owners, and the balance sheet.
- Reinvested$2.7B · 36%
- Dividends$1.6B · 21%
- Buybacks$1.1B · 15%
- Retained (debt / cash)$2.2B · 28%
- Returned to owners$2.7B
56% of the owner earnings the business produced over the span, $1.6B as dividends and $1.1B as buybacks.
- Average price paid for buybacks$187.57
Across the years where the filing reports a share count, 4M shares were bought for $789M, about $187.57 each. Year to year the price paid ranged from $98.48 (2018) to $514.70 (2022); its heaviest year, 2023, paid $197.29 ($309M).
- Net change in share count14.6%
The diluted count rose from 86M to 99M: issuance (stock pay, deals) outran any buybacks, so owners were diluted on net.
- Dividend record$2.45/sh
Paid in 10 of the years on record, the per-share dividend growing about 10% a year. It was never cut over the span.
- Return on what it retained53%
Of the earnings it kept rather than paid out ($928M over the span), annual owner earnings (first three years vs last three) grew $490M, so each retained $1 added about 0.53 of yearly owner earnings. Buffett's test, run on owner earnings instead of market value.
Buybacks are gross of stock issued to staff; the share-count line above is the net of that, the figure that decides whether owners gained. The average price paid blends a year of purchases (and any accelerated repurchase), so it is close, not exact. The record of where the cash went and on what terms.
Acquisitions & goodwill
from the balance sheet & the 10-year cash-flow recordGoodwill grows only when a company acquires and falls only when it concedes it overpaid. The size of that bet, the cash put into buying rather than building, and how much has already been written off.
$549M written down across 2 years (2017, 2023): goodwill the company has already conceded it overpaid for, charged against earnings. That is roughly 23% of the cash it put into acquisitions over the span. A write-down costs no cash (the cash went out when the deal was signed), but it is management marking its own past judgment to market.
Goodwill, acquired intangibles and equity from the latest balance sheet; acquisition spend and write-downs summed across the 10-year record, from the company's own filings.
Management, ownership & pay
read the proxy →From the proxy: how much of the business the people running it own, and how they are paid, beside what the business earned for its owners in the same years.
| Fiscal year | Chief executive | Pay, as filed | “Actually paid” | Owner earnings |
|---|---|---|---|---|
| 2022 | Daniel A. Carestio | $5.9M | $11.8M | $397M |
| 2022 | Walter M Rosebrough | $1.2M | $9.6M | $397M |
| 2023 | Daniel A. Carestio | $7.7M | $2.2M | $395M |
| 2024 | Daniel A. Carestio | $9.6M | $14.1M | $613M |
| 2025 | Daniel A. Carestio | $10.7M | $7.9M | $778M |
| 2026 | Daniel A. Carestio | $11.5M | $3.3M | $972M |
Both pay figures are the company’s own, from the pay-versus-performance table its proxy statement files. “As filed” is the Summary Compensation Table total: salary, bonus, and equity awards at their value on the day of grant. “Actually paid” is the SEC’s prescribed recalculation, which re-marks those equity awards to what they became as they vested; it can swing far above or below the filed figure in either direction, and negative years occur. Owner earnings are the whole business's, from the record above, for the same fiscal years.
- CEO pay ratio157:1
What the chief earns for every dollar the median employee makes, per the 2026 proxy. A high ratio alone settles nothing; some businesses are genuinely top-heavy in scarce skill. A runaway figure is where Buffett starts asking whether the board is doing its job.
- Stock-based compensation$62M
The slice of the business handed to employees in shares this year, 1% of revenue, equal to 6% of operating profit. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.
Inverting the record
Invert: instead of why Steris is a good business, the question is what would make owning it a mistake, and whether those marks are in the record. Disconfirming tests across 2017–2026.
1 of the 4 tests turned up something to look into; the other 3 came back clean.
- Look hereDid the share count rise anyway?14.6%
Diluted shares grew 14.6% over 2017–2026, even as the company spent $1.1B on buybacks. The repurchases were outrun by issuance — to staff, in a raise, or in a deal — and the filing says which; owners' slice still shrank. Read the buyback line beside this one, not on its own.
- Is it less profitable than it was?
- Did reported profit become cash?
- Are "one-time" charges a yearly habit?
Each test is read from the filings and is noisy alone; a flag can mark a cyclical trough or a year of heavy investment as easily as a problem. The filing says which.
What an owner would ask, FY2026
read the 10-K →- Which reported numbers are a judgment call?Management names Revenue recognition, Pension & retirement, Income taxes as critical estimates
each rests partly on management's judgment; the filing's note sets out the assumptionsverify →
The questions the record and the charts do not answer on their own; each carries the figure and the place to look.
Peers, Medical Devices & Equipment
The same industry, side by side on owner economics. Each figure is a through-cycle median, so a peak or trough year can’t distort it; the group median at the foot is the line to read each against.
| Company | Revenue | Gross margin | Op. margin | ROIC | Owner earn. margin |
|---|---|---|---|---|---|
| BAXBaxter International Inc. | $11.2B | 40% | 9.2% | 6% | 10% |
| SOLVSolventum Corporation | $8.3B | — | 20.7% | 12% | 14% |
| TDYTeledyne Technologies Incorporated | $6.1B | 40% | 16.5% | 10% | 16% |
| STESteris | $5.9B | 43% | 16.1% | 8% | 12% |
| COHRCoherent Corp. | $5.8B | 38% | 11.0% | 8% | 6% |
| WSTWest Pharmaceutical | $3.1B | 35% | 19.0% | 19% | 17% |
| ENOVEnovis Corporation | $2.2B | 55% | -4.4% | -1% | 1% |
| MSAMSA Safety Incorporated | $1.9B | 45% | 13.2% | 13% | 11% |
| Group median | — | 40% | 14.6% | 9% | 12% |
The price
What a price has to assume.
What the price implies
reverse-DCFType today's close and see the owner-earnings growth you'd have to believe to justify it, beside what Steris has delivered.
Steris’s latest year runs above its own through-cycle margin — the reported figure may flatter a peak. So the tool opens on the through-cycle base, Graham’s averaging cutting both ways; clear the toggle below to read the latest year exactly as reported.
Through the cycle, Steris earns about $722M on its 12.2% median owner-earnings margin. This year’s 16.4% margin runs above that; the reported figure may flatter a peak you'd be paying on. Normalize, below, values the price on that through-cycle figure rather than the latest year. It comes pre-checked here for that reason, the same rule that already normalizes a trough; clear it to price the year as filed.
—
9.0% = the 4.55% 10-year Treasury (Jul 15, 2026) + 4.45 points of equity premium. The rate you require is yours to set.
Enter a price above to run it.
A dated snapshot of the price you typed, the assumptions you set, and what the page showed for them. A snapshot is never edited after it is saved. Your notebook is yours alone — the commitment states what is stored and what we will never do.
Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.
Prefilled with the 10-year Treasury (4.55%, as of Jul 15, 2026). Edit it for today’s exact figure, or a AAA corporate yield.
Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.
Owner earnings $972M on 98M shares outstanding, per the 10-K cover, as of 2026-05-27; net debt $1.5B. The base opens on the through-cycle figure (the latest year sits above the record’s own median, and Graham’s averaging cuts both ways); clear Normalize to use the year as filed. Net of stock comp treats option pay as the expense it is. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.
Manual order: ← STC its page in the Manual STEL →
Industry order: ← STAA the Medical Devices & Equipment chapter STVN →